RxDoctor Payments Data

Christopher Surek, DO

Plastic Surgery · Cleveland, OHNPI 1114264637

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Galderma Laboratories, L.p. accounts for 62.3% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2022 at $242,538 and has fallen 57.6% since, to $102,939 in 2025. Among plastic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,024,535in general payments, 2019–2025

Across 621 payments — averaging $1649.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$638K
  • AbbVie$366K
  • Ipsen Innovation$12K
  • Sientra, Inc.$4K
  • Tepha Inc$1K
  • Davol Inc.$525
  • plus $3K from 19 others

What the payments were for

  • Consulting fees$607,70659%
  • Speaking & faculty fees$320,24031%
  • Grants$20,0002%
  • Travel & lodging$54,3425%
  • Food & beverage$22,2482%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,024,535 in reported general payments places this provider in the 95th percentile of 191 plastic surgery providers in Ohio.

See all plastic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$6,961
Medicare patients
14
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErythromycinErythromycin Base42$440
Tobramycin-DexamethasoneTobramycin/Dexamethasone12$330
Ondansetron OdtOndansetron16$84
Oxycodone Hcl15$46
Acyclovir16$42
Cephalexin13$42
Gabapentin13$17
Meloxicam14$17

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →